Eva A. Ebbing
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 7
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 2
- Pancreatic and Hepatic Oncology Research 2
- Colorectal Cancer Treatments and Studies 1
- Peptidase Inhibition and Analysis 1
-
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Hanneke W.M. van Laarhoven (10 shared papers)Maarten F. Bijlsma (10 shared papers)Kausilia Krishnawatie Krishnadath (8 shared papers)Jan Paul Medema (7 shared papers)Sybren L. Meijer (7 shared papers)Mark I. van Berge Henegouwen (6 shared papers)Anne Steins (6 shared papers)Aafke Creemers (5 shared papers)
- Journals
- Oncotarget (2 papers)Journal of Translational Medicine (2 papers)Scientific Reports (1 paper)Nucleosides Nucleotides & Nucleic Acids (1 paper)Molecular Oncology (1 paper)
- Partner nations
- NetherlandsAustraliaEgypt
In The Last Decade
Eva A. Ebbing
11 papers receiving 350 citations
Peers
Comparison fields: 5 of 53
- Oncology 218
- Cancer Research 64
- Pulmonary and Respiratory Medicine 76
- Surgery 98
- Immunology 38
Countries citing papers authored by Eva A. Ebbing
This map shows the geographic impact of Eva A. Ebbing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva A. Ebbing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva A. Ebbing more than expected).
Fields of papers citing papers by Eva A. Ebbing
This network shows the impact of papers produced by Eva A. Ebbing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva A. Ebbing. The network helps show where Eva A. Ebbing may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva A. Ebbing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 138 | |
| 2 | 2015 | 55 | |
| 3 | 2017 | 34 | |
| 4 | 2016 | 33 | |
| 5 | 2018 | 29 | |
| 6 | 2019 | 23 | |
| 7 | 2018 | 20 | |
| 8 | 2019 | 9 | |
| 9 | 2014 | 8 | |
| 10 | 2017 | 7 | |
| 11 | 2022 | 1 |
About Eva A. Ebbing
Eva A. Ebbing is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Hepatology and Cancer Research, having authored 11 papers that have together received 357 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Cells and Metastasis (3 papers), HER2/EGFR in Cancer Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Colorectal Cancer Treatments and Studies (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (218 citations), Cancer Research (64 citations), Pulmonary and Respiratory Medicine (76 citations), Surgery (98 citations) and Immunology (38 citations). Eva A. Ebbing has collaborated with scholars based in Netherlands, Australia and Egypt. Frequent co-authors include Hanneke W.M. van Laarhoven, Maarten F. Bijlsma, Kausilia Krishnawatie Krishnadath, Jan Paul Medema, Sybren L. Meijer, Mark I. van Berge Henegouwen, Anne Steins, Aafke Creemers, Maarten C.C.M. Hulshof and Cynthia Waasdorp. Their work appears in journals such as Oncotarget, Journal of Translational Medicine, Scientific Reports, Nucleosides Nucleotides & Nucleic Acids and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.